| ADR Ontology |
| ADR Term |
Adenoid cystic carcinoma |
| ADR ID |
BADD_A09416 |
| ADR Hierarchy |
|
| Description |
Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed) [MeSH] |
| MedDRA Code |
10053231 |
| MeSH ID |
D003528
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Adenoid cystic carcinoma | Adenoid cystic carcinoma metastatic | Carcinoma, Adenoid Cystic | Adenoid Cystic Carcinoma | Adenoid Cystic Carcinomas | Carcinomas, Adenoid Cystic | Cystic Carcinoma, Adenoid | Cystic Carcinomas, Adenoid | Adenocystic Carcinoma | Adenocystic Carcinomas | Carcinoma, Adenocystic | Carcinomas, Adenocystic | Cylindroma | Cylindromas |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00794 | Ergocalciferol | 0.000684% | |
| The 1th Page 1
Total 1 Pages
|
|
